arrow_back Back to App

Opioid Efficacy Review: New Clinical Trial Rules

This act requires the Food and Drug Administration (FDA) to evaluate and decide whether to permit a new clinical trial methodology (EERW) for drugs, including opioids. This aims to ensure that marketed drugs are safe and effective, directly impacting citizens' health and safety, especially those with chronic pain.
Key points
The FDA must convene an expert meeting within 2 years to decide on permitting a new drug testing method.
These studies aim to better assess the efficacy of drugs, including opioids, used for chronic pain treatment.
An independent body (National Academy of Sciences) will conduct a study and submit a report on this methodology, ensuring an objective evaluation.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_1634
Sponsor: Sen. Manchin, Joe, III [D-WV]
Process start date: 2021-05-13
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

FREED of Opioids Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_1634.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-05-13.

What are the main provisions?

Key points include:

  • The FDA must convene an expert meeting within 2 years to decide on permitting a new drug testing method.
  • These studies aim to better assess the efficacy of drugs, including opioids, used for chronic pain treatment.
  • An independent body (National Academy of Sciences) will conduct a study and submit a report on this methodology, ensuring an objective evaluation.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Manchin, Joe, III [D-WV].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health